PHARMACEUTICAL APPLICATIONS OF MARINEDERIVED LIPIDS

Abstract

Hyperlipidaemia (HLP) refers to an abnormally elevated blood lipid condition arising from dysmetabolism in lipids. In recent years, the frequency of HLP due to adverse dietary conditions has been growing with each passing year. Apart from this, pharmacological lipid-lowering drugs also in common practice have achieved greater improvement in circulating lipid levels with some side effects. Nonetheless, a range of physiological effects, including blood pressure, hypoglycemia, antioxidant, and antithrombotic properties, have been reported for the water's bioactive compounds.   As a result, the hypolipidemic impact of marine bioactive substances with intricate and twisted structures has also gained attention.    The therapeutic potential of marine-derived polysaccharides, unsaturated fatty acids, and bioactive peptides in HLP is the main focus of this investigation.  Additionally, it provides a concise overview of the main ways in which these substances demonstrate their hypolipidemic effects in vivo.